Eutilex.Co.Ltd (263050) - Total Liabilities

Latest as of September 2025: ₩22.09 Billion KRW ≈ $14.97 Million USD

Based on the latest financial reports, Eutilex.Co.Ltd (263050) has total liabilities worth ₩22.09 Billion KRW (≈ $14.97 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Eutilex.Co.Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Eutilex.Co.Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Eutilex.Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Eutilex.Co.Ltd.

Eutilex.Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Eutilex.Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Shin Poong Pap KO:002870	Korea	₩2.05 Billion
Kim Teck Cheong Consolidated Bhd KLSE:0180	Malaysia	RM275.41 Million
Seach Medical Group Ltd TA:SEMG	Israel	ILA41.42 Million
Conduril - Engenharia S.A LS:CDU	Portugal	€157.89 Million
Cho Kwang Pain KO:004910	Korea	₩219.19 Billion
WITTED MEGACORP OYJ EO 1 F:8OS	Germany	€10.25 Million
Innature Bhd KLSE:5295	Malaysia	RM80.33 Million
Lincoln Minerals Ltd AU:LML	Australia	AU$558.38K

Liability Composition Analysis (2016–2024)

This chart breaks down Eutilex.Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Eutilex.Co.Ltd's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.65	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.83	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.43	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Eutilex.Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Eutilex.Co.Ltd (2016–2024)

The table below shows the annual total liabilities of Eutilex.Co.Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩26.57 Billion ≈ $18.01 Million	+116.66%
2023-12-31	₩12.26 Billion ≈ $8.31 Million	-26.62%
2022-12-31	₩16.71 Billion ≈ $11.33 Million	-63.11%
2021-12-31	₩45.31 Billion ≈ $30.70 Million	-3.64%
2020-12-31	₩47.02 Billion ≈ $31.87 Million	+256.70%
2019-12-31	₩13.18 Billion ≈ $8.93 Million	+74.17%
2018-12-31	₩7.57 Billion ≈ $5.13 Million	+2.88%
2017-12-31	₩7.36 Billion ≈ $4.99 Million	+29.42%
2016-12-31	₩5.68 Billion ≈ $3.85 Million	--

About Eutilex.Co.Ltd

KQ:263050 Korea Biotechnology

Market Cap

$23.94 Million

₩35.32 Billion KRW

Market Cap Rank

#24620 Global

#1772 in Korea

Share Price

₩959.00

Change (1 day)

+29.95%

52-Week Range

₩683.00 - ₩1673.00

All Time High

₩41553.86